Evaluation of the use of nab-paclitaxel and gemcitabine in clinical practice. (Record no. 28869424)

MARC details
000 -LEADER
fixed length control field 01564 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518000849.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201810s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1998-4138
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.4103/0973-1482.188292
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Casanova-Martinez, Cristina
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20181030
245 00 - TITLE STATEMENT
Title Evaluation of the use of nab-paclitaxel and gemcitabine in clinical practice.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of cancer research and therapeutics
Date of publication, distribution, etc. Sep 2018
300 ## - PHYSICAL DESCRIPTION
Extent S730-S735 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Evaluation Study; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Albumins
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Deoxycytidine
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug-Related Side Effects and Adverse Reactions
General subdivision classification
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Kaplan-Meier Estimate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Paclitaxel
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pancreatic Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Gemcitabine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Romero-Ventosa, Elena Yaiza
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name González-Costas, Sonia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Arroyo-Conde, Cecilia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Piñeiro-Corrales, Guadalupe
773 0# - HOST ITEM ENTRY
Title Journal of cancer research and therapeutics
Related parts vol. 14
-- no. Supplement
-- p. S730-S735
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.4103/0973-1482.188292">https://doi.org/10.4103/0973-1482.188292</a>
Public note Available from publisher's website

No items available.